ストックスクリーナーアプリを入手
107.76
1.01%
-1.10
アフターアワーズ：
107.76
前日終値:
$108.86
開ける：
$108.86
24時間の取引高:
413.07K
Relative Volume:
0.50
時価総額：
$5.52B
収益：
$338.46M
当期純損益:
$-310.96M
株価収益率:
-16.50
EPS:
-6.53
ネットキャッシュフロー:
$-132.82M
1週間 パフォーマンス:
-3.97%
1か月 パフォーマンス:
+5.99%
6か月 パフォーマンス:
+19.64%
1年 パフォーマンス:
+46.25%
1日の値動き範囲:
$107.66
$110.16
1週間の範囲:
$107.66
$120.00
52週間の値動き範囲:
$64.11
$139.13
Axsome Therapeutics Inc Stock (AXSM) Company Profile
名前
Axsome Therapeutics Inc
セクター
電話
(212) 332-3241
住所
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
AXSM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AXSM
Axsome Therapeutics Inc
|
107.76 | 5.52B | 338.46M | -310.96M | -132.82M | -6.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Axsome Therapeutics Inc Stock (AXSM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-07 | 開始されました | Jefferies | Buy |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-31 | 繰り返されました | Mizuho | Outperform |
| 2024-09-03 | 開始されました | Wells Fargo | Overweight |
| 2024-08-06 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-07-22 | 開始されました | Needham | Buy |
| 2024-04-29 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-03-19 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-06 | 開始されました | UBS | Buy |
| 2024-01-25 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-12-13 | 開始されました | Citigroup | Buy |
| 2023-08-08 | アップグレード | BofA Securities | Underperform → Neutral |
| 2023-01-05 | 開始されました | Piper Sandler | Neutral |
| 2022-11-01 | 開始されました | Loop Capital | Buy |
| 2022-09-07 | 再開されました | Mizuho | Buy |
| 2021-08-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-10 | 開始されました | Berenberg | Buy |
| 2021-01-08 | 開始されました | Jefferies | Buy |
| 2020-12-16 | 開始されました | Mizuho | Buy |
| 2020-09-29 | 開始されました | BofA Securities | Underperform |
| 2020-09-10 | 開始されました | Morgan Stanley | Overweight |
| 2020-04-28 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-04-14 | 開始されました | Cowen | Outperform |
| 2019-12-30 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-16 | 繰り返されました | Guggenheim | Buy |
| 2019-10-16 | 開始されました | Guggenheim | Buy |
| 2019-09-18 | 開始されました | William Blair | Outperform |
| 2019-05-28 | 開始されました | SunTrust | Buy |
| 2019-05-23 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-04-08 | 開始されました | SVB Leerink | Outperform |
| 2019-03-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2016-10-03 | 再開されました | Brean Capital | Buy |
| 2015-12-15 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-12-14 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Axsome Therapeutics Inc (AXSM) 最新ニュース
Cubist Systematic Strategies LLC Purchases New Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 5.6% Following Strong Earnings - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) Posts Quarterly Earnings Results, Beats Expectations By $0.46 EPS - MarketBeat
BVF Inc. IL Has $117.44 Million Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
FY2025 EPS Estimates for AXSM Lifted by Cantor Fitzgerald - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) Issues Earnings Results - MarketBeat
Schonfeld Strategic Advisors LLC Has $2.15 Million Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics (NASDAQ:AXSM) Price Target Cut to $180.00 by Analysts at HC Wainwright - MarketBeat
FY2028 Earnings Forecast for AXSM Issued By William Blair - MarketBeat
Price T Rowe Associates Inc. MD Purchases 3,366 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information - ACCESS Newswire
Alethea Capital Management LLC Has $62.13 Million Holdings in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Short Interest Down 14.2% in April - MarketBeat
Axsome targets FDA decision on AXS-14 for fibromyalgia in Q2 2025 - MSN
Robert W. Baird Forecasts Strong Price Appreciation for Axsome Therapeutics (NASDAQ:AXSM) Stock - MarketBeat
Brevan Howard Capital Management LP Acquires 24,393 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Analysts Are Updating Their Axsome Therapeutics, Inc. (NASDAQ:AXSM) Estimates After Its First-Quarter Results - Yahoo Finance
AXSM Q1 Loss Narrower Than Expected, Auvelity Drives Revenues Y/Y - MSN
Axsome Therapeutics at Citizens JMP Life Sciences: Strategic Growth Unveiled - Investing.com India
Bridgefront Capital LLC Buys Shares of 10,555 Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares Acquired by Tower Research Capital LLC TRC - MarketBeat
Ally Bridge Group NY LLC Purchases New Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Boxer Capital Management LLC Makes New $39.77 Million Investment in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics Q1: Marketing-Driven Growth Masks Profitability Concerns (AXSM) - Seeking Alpha
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Holdings Lifted by First Trust Advisors LP - MarketBeat
Baird Raises Price Target for Axsome Therapeutics (AXSM) | AXSM Stock News - GuruFocus
Bellevue Group AG Sells 248,251 Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2025 Earnings Call Transcript - Insider Monkey
Axsome Therapeutics (AXSM) Target Price Boosted Post Q1 Update | - GuruFocus
Axsome Therapeutics (AXSM) Price Target Increased Amid Positive Outlook | AXSM Stock News - GuruFocus
Axsome Therapeutics (AXSM) Target Price Boosted Post Q1 Update | AXSM Stock News - GuruFocus
Deutsche Bank Adjusts Axsome Therapeutics Price Target to $190 From $187, Maintains Buy Rating - marketscreener.com
Avidity Partners Management LP Cuts Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Wells Fargo Increases Price Target for Axsome Therapeutics (AXSM) Amid Growth Prospects | AXSM Stock News - GuruFocus
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Stock Holdings Cut by PDT Partners LLC - MarketBeat
Axsome Therapeutics Inc (AXSM) Q1 2025 Earnings Call Highlights: Robust Revenue Growth and ... By GuruFocus - Investing.com Canada
Axsome Therapeutics Reports Strong Q1 2025 Growth - TipRanks
Axsome Therapeutics (AXSM) Reports Strong Q1 Growth and Strategi - GuruFocus
Decoding Axsome Therapeutics Inc (AXSM): A Strategic SWOT Insigh - GuruFocus
Axsome: Q1 Earnings Snapshot - MySA
Axsome Therapeutics (AXSM) Sees Stock Rise Following Earnings Re - GuruFocus
Earnings call transcript: Axsome Therapeutics beats EPS forecast in Q1 2025 - Investing.com Nigeria
Axsome Therapeutics’ Earnings Call Highlights Growth and Challenges - TipRanks
Axsome Therapeutics Inc (AXSM) Q1 2025 Earnings: EPS of $(1.22) - GuruFocus
Axsome Therapeutics (AXSM) Reports Strong Q1 Revenue and Advance - GuruFocus
Axsome Therapeutics (AXSM) Beats Q1 Expectations with Robust Rev - GuruFocus
Axsome Therapeutics Q1 2025 Earnings Preview - MSN
Axsome Therapeutics, Inc. SEC 10-Q Report - TradingView
Voya Investment Management LLC Boosts Stock Position in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - MarketBeat
Axsome Therapeutics Inc earnings beat by $0.08, revenue fell short of estimates - Investing.com Nigeria
Axsome Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat
Axsome Therapeutics Inc (AXSM) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):